PHAS | PhaseBio Pharmaceuticals Inc
Category: Consumer goods
Quick infos Headquarters: Malvern, Pennsylvania, United States Trade prices Volume: Market Cap: 30.92M Prev closed: Open: High: Low: 52 week low: 52 week high: Dividends: Next ER: November 17, 2022
Earnings History Date EPS / Forecast Revenue / Forecast March 28, 2023 November 17, 2022 - / -0.3275- / 1.25MAugust 12, 2022 -0.34 / -0.3125208K / 1.25MBeat! May 16, 2022 -0.23 / -0.664117K / 3.89MBeat! March 24, 2022 -0.9 / -0.586158K / 3.28MBeat! view more
Historical Data Date Price Open High Low Vol Change ER May 12, 2022 1.010 0.990 1.020
0.966
152.19K 2.21% May 11, 2022 0.988 1.080 1.130
0.980
507.51K -10.16% May 10, 2022 1.100 1.000 1.170
0.990
642.57K 13.39% May 9, 2022 0.970 1.010 1.030
0.970
474.77K -7.61% May 6, 2022 1.050 1.100 1.120
0.990
1.07M -4.55% May 5, 2022 1.100 1.150 1.190
1.020
567.06K -9.09% May 4, 2022 1.210 1.190 1.250
1.000
1.07M 0.83% May 3, 2022 1.200 1.250 1.320
1.170
205.29K -3.23% May 2, 2022 1.240 1.210 1.260
1.160
400.06K 2.48% Apr 29, 2022 1.210 1.090 1.260
1.090
276.23K 10% view more
News
Earnings Update: PhaseBio Pharmaceuticals, Inc. (NASDAQ:PHAS) Just Reported And Analysts Are Trimming Their Forecasts finance.yahoo.com Nov 16, 2020 6:22 am
PhaseBio to Present at the Stifel 2020 Virtual Healthcare Conference on November 18th finance.yahoo.com Nov 11, 2020 5:33 pm
PhaseBio Provides Pemziviptadil (PB1046) Program Update finance.yahoo.com Oct 23, 2020 8:00 am
PhaseBio Doses First Patients in Canada as Part of the REVERSE-IT Global Phase 3 Trial of Bentracimab for Reversal of the Antiplatelet Effects of Ticagrelor finance.yahoo.com Oct 6, 2020 8:00 am
PHASEBIO PHARMA (PHAS) Reports Q2 Loss, Lags Revenue Estimates finance.yahoo.com Aug 21, 2020 8:16 am PhaseBio Pharmaceuticals EPS misses by $0.47 seekingalpha.com Aug 12, 2020 4:23 am Why PhaseBio's stock rose 16 percent Tuesday bizjournals.com Aug 11, 2020 4:30 pm
PhaseBio Reports First Quarter 2020 Financial Results and Recent Business Highlights finance.yahoo.com Aug 11, 2020 4:01 pm
PhaseBio's IPO: What You Need To Know finance.yahoo.com Aug 11, 2020 1:19 pm PhaseBio shares soar 28% premarket as FDA speeds path for approval of PB2452 marketwatch.com Aug 11, 2020 7:59 am Mid-stage study underway on PhaseBio's PB1046 for COVID-19 seekingalpha.com Jul 17, 2020 4:20 am PhaseBio gets FDA OK for clinical trial of COVID-19 treatment seekingalpha.com May 28, 2020 7:00 am
PhaseBio Stock Up on Breakthrough Therapy Status for PB2452 finance.yahoo.com Aug 11, 2020 11:24 am
P/E Ratio Insights for PhaseBio Pharmaceuticals finance.yahoo.com Aug 11, 2020 10:40 am
PhaseBio Announces Financing and Co-Development Collaboration with SFJ Pharmaceuticals® for PB2452 finance.yahoo.com Aug 11, 2020 9:00 am
The Daily Biotech Pulse: PhaseBio To Start Potential Pivotal COVID-19 Trial, Immunomedics CEO Quits, Tetraphase Receives Sweetened Offer finance.yahoo.com Aug 11, 2020 8:24 am
PhaseBio To Report Fourth Quarter and Full-Year 2018 Financial and Business Results on March 26, 2019 finance.yahoo.com Aug 11, 2020 8:00 am
PhaseBio Reports Third Quarter 2019 Financial Results and Recent Corporate Progress finance.yahoo.com Aug 11, 2020 8:00 am
The Daily Biotech Pulse: PhaseBio Pumped Up, Eiger Exults On Breakthrough Therapy Designation, Biohaven Slips On Stock Sale finance.yahoo.com Aug 11, 2020 7:31 am
Analysts Estimate PHASEBIO PHARMA (PHAS) to Report a Decline in Earnings: What to Look Out for finance.yahoo.com Aug 4, 2020 12:30 pm Talk about PhaseBio Pharmaceuticals Inc below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. This profile is based on publicly available information and is intended to be informative in nature. Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
If you want to help pay for server cost or for improving this tool. You can send it via Paypal . More features coming soon :)
Buy on Amazon In the world of investing, slow and steady wins the race. With this mantra in mind, trusted author and finance guru Eric Tyson is back with the latest edition of the #1 bestselling book, Investing For Dummies, to help you achieve your investment goals.